Administration of Recombinant Human GHRH-1,44-amide for 3 Months Reduces Abdominal Visceral Fat Mass and Increases Physical Performance Measures in Postmenopausal Women

European Journal of Endocrinology - United Kingdom
doi 10.1530/eje.1.02019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica


Related search